パニツムマブの世界市場2019

GlobalInfoResearchが発行した調査報告書（GIR9101819）

◆英語タイトル：Global Panitumumab Market 2019 by Company, Regions, Type and Application, Forecast to 2024
◆商品コード：GIR9101819
◆発行会社（リサーチ会社）：GlobalInfoResearch
◆発行日：2019年9月（※2024年版があります。お問い合わせください）
◆ページ数：100
◆レポート形式：英語 / PDF
◆納品方法：Eメール
◆調査対象地域：グローバル
◆産業分野：製薬・医療
◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,480 ⇒換算￥515,040	見積依頼/購入/質問フォーム
Multi User（10名様閲覧用）	USD5,220 ⇒換算￥772,560	見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）	USD6,960 ⇒換算￥1,030,080	見積依頼/購入/質問フォーム

★GlobalInfoResearchに受託調査の見積を依頼する

※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。

本調査レポートは、パニツムマブの世界市場について調べ、まとめました。種類別セグメントは、100 mg / 5 mL単回投与バイアル、400 mg / 20 mL単回投与バイアル等、用途別セグメントは、病院、薬局等に区分しました。パニツムマブの世界市場概観、企業動向、企業別パニツムマブシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。
・パニツムマブの市場概観
・パニツムマブの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等）
・パニツムマブの企業別販売動向、市場シェア、市場集中度、競争動向
・パニツムマブの世界市場規模
・パニツムマブの北米市場分析（アメリカ、カナダ、メキシコ等）
・パニツムマブのアメリカ市場規模推移
・パニツムマブのカナダ市場規模推移
・パニツムマブのメキシコ市場規模推移
・パニツムマブのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等）
・パニツムマブのドイツ市場規模推移
・パニツムマブのイギリス市場規模推移
・パニツムマブのロシア市場規模推移
・パニツムマブのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等）
・パニツムマブの日本市場規模推移
・パニツムマブの中国市場規模推移
・パニツムマブの韓国市場規模推移
・パニツムマブのインド市場規模推移
・パニツムマブの東南アジア市場規模推移
・パニツムマブの南米市場分析（ブラジル、アルゼンチン等）
・パニツムマブの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等）
・パニツムマブの種類別分析/販売量、売上、市場シェア（100 mg / 5 mL単回投与バイアル、400 mg / 20 mL単回投与バイアル）
・パニツムマブの用途別分析/市場規模（病院、薬局）
・パニツムマブの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測）
・パニツムマブの販売チャネル・代理店・貿易業者・ディーラー分析

【レポートの概要】

Panitumumab (INN), formerly ABX-EGF, is a fully human monoclonal antibody specific to the epidermal growth factor receptor (also known as EGF receptor, EGFR, ErbB-1 and HER1 in humans).

Scope of the Report:
The global Panitumumab market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Panitumumab.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Panitumumab market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Panitumumab market by product type and applications/end industries.

Market Segment by Companies, this report covers
Amgen

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
100 mg/5 mL single-dose vials
400 mg/20 mLsingle-dose vials

Market Segment by Applications, can be divided into
Hospital
Drug store

【レポートの目次】

Table of Contents

1 Panitumumab Market Overview
1.1 Product Overview and Scope of Panitumumab
1.2 Classification of Panitumumab by Types
1.2.1 Global Panitumumab Revenue Comparison by Types (2019-2024)
1.2.2 Global Panitumumab Revenue Market Share by Types in 2018
1.2.3 100 mg/5 mL single-dose vials
1.2.4 400 mg/20 mLsingle-dose vials
1.3 Global Panitumumab Market by Application
1.3.1 Global Panitumumab Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospital
1.3.3 Drug store
1.4 Global Panitumumab Market by Regions
1.4.1 Global Panitumumab Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Panitumumab Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Panitumumab Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Panitumumab Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Panitumumab Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Panitumumab Status and Prospect (2014-2024)
1.5 Global Market Size of Panitumumab (2014-2024)
2 Manufacturers Profiles
2.1 Amgen
2.1.1 Business Overview
2.1.2 Panitumumab Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Amgen Panitumumab Revenue, Gross Margin and Market Share (2017-2018)
3 Global Panitumumab Market Competition, by Players
3.1 Global Panitumumab Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Panitumumab Players Market Share
3.2.2 Top 10 Panitumumab Players Market Share
3.3 Market Competition Trend
4 Global Panitumumab Market Size by Regions
4.1 Global Panitumumab Revenue and Market Share by Regions
4.2 North America Panitumumab Revenue and Growth Rate (2014-2019)
4.3 Europe Panitumumab Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Panitumumab Revenue and Growth Rate (2014-2019)
4.5 South America Panitumumab Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Panitumumab Revenue and Growth Rate (2014-2019)
5 North America Panitumumab Revenue by Countries
5.1 North America Panitumumab Revenue by Countries (2014-2019)
5.2 USA Panitumumab Revenue and Growth Rate (2014-2019)
5.3 Canada Panitumumab Revenue and Growth Rate (2014-2019)
5.4 Mexico Panitumumab Revenue and Growth Rate (2014-2019)
6 Europe Panitumumab Revenue by Countries
6.1 Europe Panitumumab Revenue by Countries (2014-2019)
6.2 Germany Panitumumab Revenue and Growth Rate (2014-2019)
6.3 UK Panitumumab Revenue and Growth Rate (2014-2019)
6.4 France Panitumumab Revenue and Growth Rate (2014-2019)
6.5 Russia Panitumumab Revenue and Growth Rate (2014-2019)
6.6 Italy Panitumumab Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Panitumumab Revenue by Countries
7.1 Asia-Pacific Panitumumab Revenue by Countries (2014-2019)
7.2 China Panitumumab Revenue and Growth Rate (2014-2019)
7.3 Japan Panitumumab Revenue and Growth Rate (2014-2019)
7.4 Korea Panitumumab Revenue and Growth Rate (2014-2019)
7.5 India Panitumumab Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Panitumumab Revenue and Growth Rate (2014-2019)
8 South America Panitumumab Revenue by Countries
8.1 South America Panitumumab Revenue by Countries (2014-2019)
8.2 Brazil Panitumumab Revenue and Growth Rate (2014-2019)
8.3 Argentina Panitumumab Revenue and Growth Rate (2014-2019)
8.4 Colombia Panitumumab Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Panitumumab by Countries
9.1 Middle East and Africa Panitumumab Revenue by Countries (2014-2019)
9.2 Saudi Arabia Panitumumab Revenue and Growth Rate (2014-2019)
9.3 UAE Panitumumab Revenue and Growth Rate (2014-2019)
9.4 Egypt Panitumumab Revenue and Growth Rate (2014-2019)
9.5 Nigeria Panitumumab Revenue and Growth Rate (2014-2019)
9.6 South Africa Panitumumab Revenue and Growth Rate (2014-2019)
10 Global Panitumumab Market Segment by Type
10.1 Global Panitumumab Revenue and Market Share by Type (2014-2019)
10.2 Global Panitumumab Market Forecast by Type (2019-2024)
10.3 100 mg/5 mL single-dose vials Revenue Growth Rate (2014-2024)
10.4 400 mg/20 mLsingle-dose vials Revenue Growth Rate (2014-2024)
11 Global Panitumumab Market Segment by Application
11.1 Global Panitumumab Revenue Market Share by Application (2014-2019)
11.2 Panitumumab Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2014-2019)
11.4 Drug store Revenue Growth (2014-2019)
12 Global Panitumumab Market Size Forecast (2019-2024)
12.1 Global Panitumumab Market Size Forecast (2019-2024)
12.2 Global Panitumumab Market Forecast by Regions (2019-2024)
12.3 North America Panitumumab Revenue Market Forecast (2019-2024)
12.4 Europe Panitumumab Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Panitumumab Revenue Market Forecast (2019-2024)
12.6 South America Panitumumab Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Panitumumab Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Panitumumab Picture
Table Product Specifications of Panitumumab
Table Global Panitumumab and Revenue (Million USD) Market Split by Product Type
Figure Global Panitumumab Revenue Market Share by Types in 2018
Figure 100 mg/5 mL single-dose vials Picture
Figure 400 mg/20 mLsingle-dose vials Picture
Table Global Panitumumab Revenue (Million USD) by Application (2014-2024)
Figure Panitumumab Revenue Market Share by Applications in 2018
Figure Hospital Picture
Figure Drug store Picture
Table Global Market Panitumumab Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Panitumumab Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Panitumumab Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Panitumumab Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Panitumumab Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Panitumumab Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Panitumumab Revenue (Million USD) and Growth Rate (2014-2024)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Panitumumab Type and Applications
Table Amgen Panitumumab Revenue, Gross Margin and Market Share (2017-2018)
Table Global Panitumumab Revenue (Million USD) by Players (2014-2019)
Table Global Panitumumab Revenue Share by Players (2014-2019)
Figure Global Panitumumab Revenue Share by Players in 2017
Figure Global Panitumumab Revenue Share by Players in 2018
Figure Global Top 5 Players Panitumumab Revenue Market Share in 2018
Figure Global Top 10 Players Panitumumab Revenue Market Share in 2018
Figure Global Panitumumab Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Panitumumab Revenue (Million USD) by Regions (2014-2019)
Table Global Panitumumab Revenue Market Share by Regions (2014-2019)
Figure Global Panitumumab Revenue Market Share by Regions (2014-2019)
Figure Global Panitumumab Revenue Market Share by Regions in 2018
Figure North America Panitumumab Revenue and Growth Rate (2014-2019)
Figure Europe Panitumumab Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Panitumumab Revenue and Growth Rate (2014-2019)
Figure South America Panitumumab Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Panitumumab Revenue and Growth Rate (2014-2019)
Table North America Panitumumab Revenue by Countries (2014-2019)
Table North America Panitumumab Revenue Market Share by Countries (2014-2019)
Figure North America Panitumumab Revenue Market Share by Countries (2014-2019)
Figure North America Panitumumab Revenue Market Share by Countries in 2018
Figure USA Panitumumab Revenue and Growth Rate (2014-2019)
Figure Canada Panitumumab Revenue and Growth Rate (2014-2019)
Figure Mexico Panitumumab Revenue and Growth Rate (2014-2019)
Table Europe Panitumumab Revenue (Million USD) by Countries (2014-2019)
Figure Europe Panitumumab Revenue Market Share by Countries (2014-2019)
Figure Europe Panitumumab Revenue Market Share by Countries in 2018
Figure Germany Panitumumab Revenue and Growth Rate (2014-2019)
Figure UK Panitumumab Revenue and Growth Rate (2014-2019)
Figure France Panitumumab Revenue and Growth Rate (2014-2019)
Figure Russia Panitumumab Revenue and Growth Rate (2014-2019)
Figure Italy Panitumumab Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Panitumumab Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Panitumumab Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Panitumumab Revenue Market Share by Countries in 2018
Figure China Panitumumab Revenue and Growth Rate (2014-2019)
Figure Japan Panitumumab Revenue and Growth Rate (2014-2019)
Figure Korea Panitumumab Revenue and Growth Rate (2014-2019)
Figure India Panitumumab Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Panitumumab Revenue and Growth Rate (2014-2019)
Table South America Panitumumab Revenue by Countries (2014-2019)
Table South America Panitumumab Revenue Market Share by Countries (2014-2019)
Figure South America Panitumumab Revenue Market Share by Countries (2014-2019)
Figure South America Panitumumab Revenue Market Share by Countries in 2018
Figure Brazil Panitumumab Revenue and Growth Rate (2014-2019)
Figure Argentina Panitumumab Revenue and Growth Rate (2014-2019)
Figure Colombia Panitumumab Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Panitumumab Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Panitumumab Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Panitumumab Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Panitumumab Revenue Market Share by Countries in 2018
Figure Saudi Arabia Panitumumab Revenue and Growth Rate (2014-2019)
Figure UAE Panitumumab Revenue and Growth Rate (2014-2019)
Figure Egypt Panitumumab Revenue and Growth Rate (2014-2019)
Figure Nigeria Panitumumab Revenue and Growth Rate (2014-2019)
Figure South Africa Panitumumab Revenue and Growth Rate (2014-2019)
Table Global Panitumumab Revenue (Million USD) by Type (2014-2019)
Table Global Panitumumab Revenue Share by Type (2014-2019)
Figure Global Panitumumab Revenue Share by Type (2014-2019)
Figure Global Panitumumab Revenue Share by Type in 2019
Table Global Panitumumab Revenue Forecast by Type (2019-2024)
Figure Global Panitumumab Market Share Forecast by Type (2019-2024)
Figure Global 100 mg/5 mL single-dose vials Revenue Growth Rate (2014-2019)
Figure Global 400 mg/20 mLsingle-dose vials Revenue Growth Rate (2014-2019)
Table Global Panitumumab Revenue by Application (2014-2019)
Table Global Panitumumab Revenue Share by Application (2014-2019)
Figure Global Panitumumab Revenue Share by Application (2014-2019)
Figure Global Panitumumab Revenue Share by Application in 2019
Table Global Panitumumab Revenue Forecast by Application (2019-2024)
Figure Global Panitumumab Market Share Forecast by Application (2019-2024)
Figure Global Hospital Revenue Growth Rate (2014-2019)
Figure Global Drug store Revenue Growth Rate (2014-2019)
Figure Global Panitumumab Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Panitumumab Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Panitumumab Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Panitumumab Revenue Market Forecast (2019-2024)
Figure Europe Panitumumab Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Panitumumab Revenue Market Forecast (2019-2024)
Figure South America Panitumumab Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Panitumumab Revenue Market Forecast (2019-2024)

【掲載企業】

Amgen、

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ パニツムマブの世界市場2019(Global Panitumumab Market 2019 by Company, Regions, Type and Application, Forecast to 2024)]についてメールでお問い合わせはこちらでお願いします。

グローバル市場調査/マーケットリサーチ会社：レポート販売と委託調査サービス提供 GlobalResearch.jp